CAS 110522-74-2
:pheac-deoxyadenosine
Description:
Pheac-deoxyadenosine, identified by its CAS number 110522-74-2, is a nucleoside analog that features a modified structure of deoxyadenosine. This compound is characterized by the presence of a phenyl group, which is typically attached to the sugar moiety, influencing its biological activity and interaction with nucleic acid structures. As a nucleoside, it consists of a purine base (adenine) linked to a deoxyribose sugar, which is essential for its role in various biochemical processes. Pheac-deoxyadenosine is of interest in medicinal chemistry and molecular biology due to its potential applications in antiviral and anticancer therapies, as it may interfere with nucleic acid synthesis or function. Its unique structural modifications can enhance its stability and selectivity towards specific biological targets. Additionally, the compound's solubility, reactivity, and pharmacokinetic properties are crucial for its efficacy in therapeutic contexts. Further research is often required to fully elucidate its mechanisms of action and potential therapeutic benefits.
Formula:C18H19N5O5
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
2'-Deoxy-N6-Phenoxyacetyladenosine
CAS:<p>2’-Deoxynucleoside,2/6/8-Modified nucleoside</p>Formula:C18H19N5O5Color and Shape:SolidMolecular weight:385.372'-Deoxy-N6-phenoxyacetyladenosine
CAS:<p>2'-Deoxy-N6-phenoxyacetyladenosine is a cyclic oligonucleotide analog that has been shown to be efficient in inhibiting the replication of RNA. It binds to the RNA polymerase, preventing transcription and replication of the nucleic acid. 2'-Deoxy-N6-phenoxyacetyladenosine is also an effective inhibitor of DNA synthesis and can inhibit the synthesis of proteins by binding to ribosomes. This drug is structurally similar to deoxyadenosine, which is a component of DNA, and it has been shown to be more potent than other analogs.</p>Formula:C18H19N5O5Purity:Min. 97 Area-%Molecular weight:385.38 g/mol
